EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Suprachoroidal Triamcinolone Plus Intravitreal Bevacizumab Versus Bevacizumab Alone for Diabetic Macular Edema in Pseudophakic Eyes: A randomized controlled trial

Imran Ahmad, Yousaf Jamal Mahsood

Pakistan Journal of Medical Sciences · 02.06.2026 · 42 (6) · 1377-1382

DOI: 10.12669/pjms.42.6.14576 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Pakistan Journal of Medical Sciences, online erschienen am 02.06.2026. Verfasst von Imran Ahmad und 1 weiteren Autor:innen. Beteiligte Einrichtung: Imran Ahmad, (MBBS, MRCS.Ed, FICO, FACS, FCPS, FCPS-Vitreoretina, MHPE) Associate Professor, Department of Ophthalmology, Khyber Medical College, Khy…. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine the efficacy of intravitreal bevacizumab (IVB) monotherapy versus a combination of IVB and suprachoroidal triamcinolone acetonide (SCTA) followed by monthly IVB in pseudophakic eyes with center-involving diabetic macular edema (DME). Methodology: The Ophthalmology Department of Khyber Teaching Hospital conducted this randomized controlled study between April 2023 to February 2024. Eighty-two pseudophakic patients with center-involving DME were randomly divided into two groups (41 each). The monotherapy group (Group-I) received a monthly injection of IVB (1.25mg/0.05 mL) for three months. The combination therapy group (Group-II) received combination of IVB (1.25 mg/0.05 mL) and SCTA (4 mg/0.1 mL) injections at first visit which were then followed by monthly IVB injection for next two months. Best-corrected visual acuity (BCVA) and central macular thickness (CMT) were measured at baseline and at four months.

Results

Both groups showed statistically significant improvement in BCVA and CMT from baselines. In Group-I, BCVA improved from 0.90±0.31 to 0.69±0.31 (p

Schlagwörter

Stichwörter der Autor:innen

BevacizumabDiabetic macular edemaIntravitreal injectionsSuprachoroidalTriamcinolone acetonide

Autor:innen und Institutionen

  • Imran Ahmad, (MBBS, MRCS.Ed, FICO, FACS, FCPS, FCPS-Vitreoretina, MHPE) Associate Professor, Department of Ophthalmology, Khyber Medical College, Khyber Teaching Hospital, Peshawar, Pakistan.
  • Yousaf Jamal Mahsood, (MBBS, MHR, MRCSEd, FICO, FRCS, FCPS), Associate Professor, Department of Ophthalmology, Khyber Girls Medical College, Hayatabad Medical Complex, Peshawar, Pakistan.

Zitieren

APA

Ahmad, I., & Mahsood, Y. J. (2026). Suprachoroidal Triamcinolone Plus Intravitreal Bevacizumab Versus Bevacizumab Alone for Diabetic Macular Edema in Pseudophakic Eyes: A randomized controlled trial. Pakistan Journal of Medical Sciences, 42(6), 1377-1382. https://doi.org/10.12669/pjms.42.6.14576

Vancouver

Ahmad I, Mahsood YJ. Suprachoroidal Triamcinolone Plus Intravitreal Bevacizumab Versus Bevacizumab Alone for Diabetic Macular Edema in Pseudophakic Eyes: A randomized controlled trial. Pakistan Journal of Medical Sciences. 2026;42(6):1377-1382. doi:10.12669/pjms.42.6.14576

BibTeX
@article{Ahmad2026,
  author = {Ahmad, Imran and Mahsood, Yousaf Jamal},
  title = {Suprachoroidal Triamcinolone Plus Intravitreal Bevacizumab Versus Bevacizumab Alone for Diabetic Macular Edema in Pseudophakic Eyes: A randomized controlled trial},
  journal = {Pakistan Journal of Medical Sciences},
  year = {2026},
  volume = {42},
  number = {6},
  pages = {1377--1382},
  doi = {10.12669/pjms.42.6.14576}
}
Kostenlos starten →